Lineage Announces a Grand Prize of $50,000 for the Food Chain Innovation Challenge
5.9.2024 15:31:00 EEST | Business Wire | Press release
Lineage, Inc. (NASDAQ: LINE) (the “Company”), the world’s largest global temperature-controlled warehouse REIT, today announced additional details of its flagship competition, the Food Chain Innovation Challenge, including members of the judging panels as well as the grand prize.
The challenge of creating impactful solutions for food waste comes at a critical time, as the severely food-insecure population is expected to hit nearly a billion people by 2028. Lineage’s global competition invites students and startups to pitch their innovative technologies or data solutions that address postharvest food waste.
The Food Chain Innovation Challenge will take place in three major locations: London on November 14, and Amsterdam and San Francisco both on November 19. Students, startups and other relevant candidates interested in participating can submit their applications online until September 30.
During each event, participants will present solutions aimed at mitigating food waste to an esteemed regional judging panel. Judges will select a regional winner, who will be awarded a $5,000 cash prize and a spot in the grand final event on December 2. One winner will then be chosen to receive the $50,000 grand prize and an invite into a six-month, executive-led incubator program tailored to their unique business goals.
London
The London event will take place on November 14, 2024, at The Science Museum. Lineage’s Regional Vice President, Clare Walters, will join a panel of distinguished judges including Simon Millard, Director of Food at FareShare; Harriet Lamb, CEO of WRAP; and Paul Randle, from the Cambridge Institute for Sustainable Leaders at Cambridge University. To support the aspiring innovators, ReLondon and FoodCycle are also partnering with the Food Chain Innovation Challenge to provide valuable insights and coaching as applicants refine their pitches.
Amsterdam
The Amsterdam event will take place on November 19, 2024, at The NEMO Science Museum. Lineage’s European President, Harld Peters, will join a panel of distinguished judges including Toine Timmermans, Director of Samen Tegen Voedselverspilling; Enno Masurel, Professor Doctor of Sustainable Entrepreneurship at the Free University Amsterdam; and Esteban Arriaga, CEO of FEBA (European Food Banks Federation).
San Francisco
The San Francisco event will take place on November 19, 2024, at the California Academy of Sciences. Lineage’s Global Chief Operations Officer Jeff Rivera will join a panel of distinguished judges, including Angel Veza, Capital, Innovation, & Engagement Senior Manager at ReFED; Danielle Todd, Founder and Executive Director at Make Food Not Waste; and Michael Wara, Director, Climate and Energy Policy Initiative at Stanford's Woods Institute for the Environment and Senior Director, Policy at the Sustainability Accelerator within the Stanford Doerr School of Sustainability.
Greg Lehmkuhl, President and CEO of Lineage, said: “Lineage is constantly looking at how we improve the global management of food storage, transportation and distribution. Beyond our own operational improvements, the Food Chain Innovation Challenge is a platform for us to support the industry's most promising talent and innovations. By collaborating, we can develop solutions that not only address food waste but also promote sustainable practices for the long term.”
Jeff Rivera, Global Chief Operations Officer at Lineage, added: “Despite producing enough food to feed the planet, hundreds of millions of people face food insecurity every day. At Lineage, we're dedicated to transforming the food supply chain to eliminate waste and feed the world. The Food Chain Innovation Challenge exemplifies this mission, and we’re excited to highlight new solutions and innovations while supporting these entrepreneurs' journeys to turn their ideas into reality.”
At the events, participants will be asked to pitch their existing ideas across four specific areas: reducing food waste, food preservation techniques, access to nutritious food and data-driven insights and analytics.
If you're interested in participating, apply here. For a glimpse into the 2023 Hackathon, the predecessor to The Food Chain Innovation Challenge held in Amsterdam, watch this video. Also, hear insights from last year's winner to get inspired and understand the impact of winning this prestigious challenge.
About Lineage
Lineage, Inc. (NASDAQ: LINE) is the world’s largest global temperature-controlled warehouse REIT with a network of over 480 strategically located facilities totaling over 84 million square feet and approximately 3.0 billion cubic feet of capacity across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the world’s largest food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world. Learn more at onelineage.com and join us on LinkedIn, Facebook, Instagram, and X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905272650/en/
Contacts
Media Contact
Christina Wiese
Public Relations Manager
cwiese@onelineage.com
734-608-1855
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 10:00:00 EEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 10:00:00 EEST | Press release
Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens. CHMP recommendation is based on data from the Phase 3 RISE-PD trial, which compared Hopledo® with immediate release levodopa/carbidopa (LD/CD) formulation in patients with Parkinson’s disease and moderate to severe motor fluctuations. In the study, Hopledo® demonstrated a significant increase in Good ON time over immediate release LD/CD with fewer daily doses and a comparable safety profile1. Hopledo® is a first-in-class, oral, modified-release formulation of LD/CD designed for the treatment of fluctuations of Parkinson’s diseas
Enhertu ® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 09:30:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across three phase 2 trials, including DESTINY-PanTumor02, DESTINY-Lung01 and DESTINY-CRC02. In DESTINY-PanTumor02, Enhertu demonstrated a confirmed objective response rate (ORR) of 52.3% (95% confidence interval [CI]: 42.6-6
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 08:00:00 EEST | Press release
The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. The company is one of the leading suppliers of maintenance and modification serv
Seiden Law LLP States: Cambodian Businessman Leak Yim, Wrongfully Accused in Thailand, Seeks Redress in U.S. Court29.6.2026 07:00:00 EEST | Press release
Seiden Law LLP (“Seiden Law”), legal counsel for Mr. Leak Yim, a Cambodia national, and his family, announces the filing of an application in U.S. federal district court in Washington D.C., seeking court-ordered discovery to uncover the false and misleading information that may have led to mistaken prosecution in Thailand of Mr. Yim as well as his unwarranted identification to Congress as being associated with scam centers in Asia. 28 U.S.C. § 1782 (“1782”) provides powerful evidence-gathering remedies, permitting an applicant to obtain evidence in the United States to assist international proceedings. Seiden Law, a U.S. law firm with significant experience in 1782 cases, has filed this application to compel production of documents and sworn testimony from persons in the U.S. that will shed light on the circumstances surrounding recent actions against Mr. Yim. “Mr. Yim and his young family are the apparent victims of guilt by association and political persecution,” said Robert Seiden,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom